◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Sawai Group Holdings Co., Ltd. (4887) EPS 2023–2026
DATA UPDATED 2026-08-11
Sawai Group Holdings Co., Ltd. annual earnings per share (EPS) for fiscal 2026 was JPY 90.10, a decrease of 51.2% from JPY 184.45 in fiscal 2025. All figures are reported results from public filings — no estimates or projections.
4887 Annual EPS
| EPS (annual) | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|
| Diluted EPS | JPY 90M | JPY 184M | JPY 104M | JPY 96M |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
4887 Quarterly EPS
| EPS (quarterly) | 2025-06-30 |
|---|
| Diluted EPS | JPY 42M |
JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
EPS at Comparable Companies
- 1276 EPS — Jiangsu Hengrui Pharmaceuticals Co.,Ltd
- 4540 EPS — Tsumura & Co.
- 4516 EPS — Nippon Shinyaku Co., Ltd.
- 3692 EPS — Hansoh Pharmaceutical Group Company Limited
- 4553 EPS — Towa Pharmaceutical Co., Ltd.
- 4547 EPS — Kissei Pharmaceutical Co., Ltd.
More 4887 metrics: Revenue · Gross Profit · Operating Income · Net Income · Free Cash Flow
All 4887 financial statements → Interactive 4887 charts →
About TickerBase · Data methodology & sources · Privacy · Terms
TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.